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Abstract The procedure of hematopoietic stem cell trans-
plantation (HSCT) is an intense treatment approach to cure
patients from leukemia or lymphoma. Prior, during, and
after HSCT, patients experience considerable physical and
psychosocial distress. In light of the increasing number of
successfully treated patients, the need is growing for
evidence-based adjuvant therapy options, which are able to
reduce treatment-related side effects and enhance the reha-
bilitation process. Exercise constitutes to be a promising
intervention in this setting due to its multidimensional ef-
fectiveness. The purpose of this article was to review the
current knowledge in the field of exercise and HSCT. There-
fore, an electronic literature search in PubMed on the topic
was performed. Twenty-nine articles could be identified and
classified as relevant for this paper. Reviewed studies sug-
gest that exercise training is an important therapeutic ap-
proach in the supportive care for transplant patients.
Significant benefits from the exercise interventions have
been reported for physical performance, quality of life
(QoL), and fatigue status. Several other benefits, such as a
more rapid immune recovery or alleviation of therapy-
related side effects have been reported in some studies.
Future studies should address existing methodological prob-
lems, identify further effect levels of exercise and integrate a
long-term perspective for the participants in the context of
hematopoietic stem cell transplantation. Furthermore, poten-
tial biological pathways of exercise in HSCT patients should
be investigated.
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Introduction
Hematopoietic stem cell transplantation (HSCT) is the only
curative treatment for hematologic and lymphoid cancers to
date but can also be used in the treatment of solid tumors and
some non-malignant disorders [9]. HSCT varies according to
the source of the substitute stem cells; depending on whether
autologous stem cells (self-donor) or allogeneic stem cells
(histologically compatible donor) are used for transplantation.
Depending on the transplantation procedure, the duration of
hospitalization ranges from 2 to 6 weeks provided that no
major complications are incurred. Due to potential major
complications, only patients in good physical conditions, with
no or well-controlled co-morbidities up to an age of about
70 years, are usually eligible for HSCT.
Before, during, and after HSCT, patients experience
substantial physical, psychological, and psychosocial
distress and deteriorations in QoL. The prolonged treat-
ment process leads to a decline in physical functioning
due to the side effects of medical treatment [25, 28].
Patients experience these stress symptoms even when
the treatment is effective and they can be detrimental
to the long-term success of HSCT. The most relevant
treatment-related problems include:
& loss of physical performance/fitness
& fatigue
& distress and emotional problems (e.g., anxiety, depression)
& pain
& immunological/ hematological changes.
Additionally, common side effects such as GVHD, infec-
tions, diarrhea, serious oral mucositis, nausea, and pain [3,
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11] exacerbate the physical and psychological problems.
Moreover, several other factors such as isolation during
hospitalization, rapid and unsteady changes in the clinical
status and the not unsubstantial risk of dying from the
procedure are a strain on the patients and can increase the
symptom burden.
In summation, all of these various physical and psycho-
social stress factors and problems massively affect the indi-
vidual QoL of each patient [1, 6, 27]. Moreover, QoL after
transplantation is often adversely influenced by problems of
reintegration into the community [30]. As described by
Backer et al. [3], some of the affected persons are complete-
ly or partly unable to perform successfully in their previous
social role functions. The treatment-related psychophysical
problems described above also contribute to the reintegra-
tion difficulties. Furthermore, long-term survivors of HSCT
are more likely to develop diabetes, cardiovascular diseases,
osteoporosis, exercise-induced shortness of breath, and oth-
er ailments [2, 31].
At present, there is a growing interest in interventions
which can help to alleviate these problems. Physical exer-
cise therapy constitutes a potentially promising adjuvant
intervention for HSCT patients because of its multidimen-
sional effectiveness.
Exercise intervention studies
Until today, 29 publications in the field of exercise in
patients prior to, during, or after HSCT have been published.
These publications draw evidence from 23 separate clinical
studies. A total of 1,177 patients with different hematolog-
ical malignancies have been enrolled in these studies. The
sample size of the individual studies varied from 12 to 135
patients. The majority of the participants (721=61.3 %)
received allogeneic stem cell transplantation.
As a rule, exercise interventions were implemented dur-
ing and/or after the hospitalization phase. Nine out of 23
studies evaluated the effects of endurance training, whereas
only two studies investigated specific effects of isolated
resistance training. The majority of studies (n=12) investi-
gated a combination of endurance and resistance training
with one study including relaxation exercises as a third part
of their intervention concept [21, 22].
Outcomes
Patients appeared to benefit from aerobic exercise regardless
of whether the endurance training was performed in an
inpatient, outpatient, or home-based setting. The three stud-
ies that focused on exercise in an inpatient setting [4, 5, 14,
21, 33] showed that regular endurance training may not lead
to an increase in endurance performance, but the loss of
performance in the experimental groups was significantly
lower than in control groups. Retrospective rehabilitation
data analyzed by Morris et al. [29] even did not show
improvements in endurance performance either, whereas a
subgroup of 40 % demonstrated improvement under gluco-
corticoid therapy. Non-randomized aerobic exercise inter-
vention studies which started during the inpatient setting
and were continued in the outpatient context, respectively,
took place in the outpatient setting only, showed significant-
ly enhanced endurance values in pre-/post-comparisons [7,
13, 18]. These results were supported by randomized con-
trolled trials in the outpatient setting also showing substan-
tial improvement in endurance performance compared to the
control groups [15, 24, 33].
Similar to the aerobic exercise interventions data, studies
focusing on resistance training could only show stabilizing
effects in strength performance, but no improvement, during
the course of inpatient treatment. One study noted increased
isometric muscle strength values for the lower body in the
experimental group in their in-/outpatient trial but no signif-
icant effects for upper body muscles [33]. Comparable data
could be shown by others [4, 16, 26]. However, a Danish
researcher group showed significant effects in muscle
strength between experimental and control group in relative-
ly small allo-HSCT study population [21]. Another publica-
tion reported significant increases in strength values in their
outpatient trial, also showing that the effect was maintained
up to a 3-month follow-up [24].
Regarding body weight and composition, two studies
[8, 17] showed increases after regular resistance and
endurance training. In the study of Coleman et al. [8],
fat-free mass increased in the exercise group, whereas
the controls lost weight during the same time period. In
the study performed by Hayes et al. [17], the experi-
mental group evidenced a reduced percentage of body
fat, an enhanced fat-free mass and a significant increase
in total energy expenditure compared with pre-treatment
measurements. Cunningham et al. [10] on the other
hand, did not find any significant changes between body
composition values in patients.
In case of immunological changes, the study done by
Dimeo et al. [14] showed that patients who performed a
daily endurance training had a significantly shorter duration
of neutropenia in comparison to the non-exercising controls.
Additionally, there was a trend toward shorter duration of
thrombopenia. Kim et al. [23] reported a significant im-
provement in the lymphocyte count in patients who per-
formed a daily 30-min exercise program in bed for
6 weeks. Lymphocyte counts among controls decreased
significantly, whereas the values of the exercisers remained
steady. In contrast to those findings, another study, who
examined the number and function of lymphocytes and
leukocytes, did not observe any significant differences
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between the experimental and control groups at the end of
the intervention [20].
Most exercise studies among HSCT patients investigated
several dimensions of quality of life (QoL) including phys-
ical function and emotional/distressing aspects, severity of
treatment- and/or disease-related side effects as well as
overall QoL scores. The studies mostly demonstrated
improvements regarding overall QoL and physical function-
ing in exercisers versus deteriorations among controls [5,
12, 19, 24, 32, 33].
As discussed above, fatigue is a common and serious side
effect in HSCT. Several studies showed that the patient’s
status of fatigue can be positively altered by exercise. Ran-
domized controlled data from our working group [33] support
these findings, revealing a significant better development of
fatigue symptoms in the experimental group (up to +15 %)
compared to controls (up to −28 %). A study done by
Carlson et al. [7] also showed highly significant interven-
tion effects on fatigue after a 12-week outpatient treatment.
These improvements in fatigue were almost completely
maintained over the 1-year follow-up measurement period.
Wilson et al. [32] noted a reduction of severity of fatigue
symptoms due to their aerobic intervention program in the
home-based setting more than 6 month after HSCT. Simi-
larly, Hacker et al. [16] showed significant improvements in
fatigue through resistance training.
Only a few studies reported on results of treatment-
related complications such as severe pain, diarrhea, muco-
sitis, cognitive problems, infections, and duration of hospi-
talization. In one study, the experimental group showed in
comparison to the control group significantly better results
for the parameters severity of diarrhea, duration of hospital-
ization, and severity of pain at time of discharge [14]. The
results concerning the severity of pain were supported by
the authors’ observation that 25 % of the patients in the
experimental group, in contrast to only 3 % in the control
group, did not need analgesia during hospitalization. Anoth-
er study evaluated data on five symptom clusters: (a) muco-
sitis, (b) cognitive, (c) gastrointestinal, (d) affective, and (e)
functional cluster. The experimental group showed signifi-
cant reduction in the severity of the symptoms in all clusters
except for those subsumed under the affective cluster (d)
[22]. Furthermore, the study done by Knols et al. showed in
their outpatient intervention a significant difference between
both groups in terms of severity of diarrhea [24].
Summary and conclusions
To date, 23 reports of the effects exercise interventions have
been published in the field of hematopoietic stem cell trans-
plantation. Fourteen of them were randomized controlled
trials. Two studies evaluated retrospective data. The major-
ity of studies (n=12) evaluated a combination of endurance
and resistance training. Due to the heterogeneity of the
intervention strategies and assessment methods used, it is
difficult to make direct comparison and to draw clear con-
clusions. In spite of these limitations, the results reported
from randomized controlled trials indicate that endurance
training/aerobic exercise or resistance training can induce
beneficial physical adaptation processes and can help to
alleviate complications and side effects (e.g., fatigue, QoL,
and distress) for patients under allogeneic as well as autol-
ogous HSCT treatment. Patients tend to be highly motivated
and adhere to the interventions. No serious adverse events
have been reported to date. Studies also suggests that there
might be an impact on immune function and recovery.
Despite the promising findings, various methodological
problems (e.g., small sample sizes or uncontrolled design)
need to be addressed in future research. The following goals
should be pursued: (1) validation of the up-to-date reported
positive results on physical performance, QoL, and
treatment-related side effects; (2) investigation of major
clinical endpoints, including length of hospitalization, recur-
rence rates, GVHD, and survival; (3) identification and
investigation on underlying biological mechanisms; and
(4) assessing exactly the dose–response so that precise and
well-aimed exercise recommendations can be made.
Future research needs also to give more consideration to
the different hematological entities, to distinguish more
between autologous and allogeneic treatment procedures
and different conditioning regimens of HSCT because dif-
fering treatment modalities and disease type have a varied
influence on patients’ initial condition and have a strong
impact on the prognosis and frequency and severity of side
effects.
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